Immunitybio Inc

NASDAQ IBRX

Data sourced from iex and EODHD
Download Data

Immunitybio Inc Income Statement 2015 - 2024

This table shows the Income Statement for Immunitybio Inc going from 2015 until 2024. The income statement, also known as the profit and loss statement, is a financial statement that provides a summary of a company's revenues, expenses, and net income over a specific period (such as a quarter or a year). It shows the company's ability to generate revenue, manage expenses, and ultimately determine its profitability.
Income Statement Trend Unit 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2018-06-30 2018-03-31 2017-12-31 2017-09-30 2017-06-30 2017-03-31 2016-12-31 2016-09-30 2016-06-30 2016-03-31 2015-12-31 2015-09-30 2015-06-30
Revenue
M 0 1 1 1 1 0 1 1 1 1 0 0 1 1 1 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Cost of Revenue
M 20 22 24 - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
Gross Profit
M -20 -21 -24 1 1 0 1 1 1 1 0 0 1 1 1 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Operating Expenses
M 325 340 338 373 367 352 346 334 341 331 319 306 271 221 170 120 85 66 68 76 87 96 104 104 99 96 96 104 115 121 174 185 235 204 127 85
Selling, General, and Administrative Expenses (SG&A)
M 139 130 123 110 95 103 104 115 131 101 83 58 33 27 21 20 18 18 19 25 34 43 51 55 55 57 59 70 85 95 154 169 223 196 121 82
Research and Development (R&D) Expenses
M 205 232 239 262 272 248 242 219 210 196 188 174 153 140 108 84 65 50 50 53 54 56 55 52 47 42 39 37 33 29 25 20 16 11 6 2
Other Operating Expenses
M -19 -21 -23 1 1 1 0 0 0 35 48 73 85 55 41 15 3 -2 -2 -2 -2 -2 -2 -3 -3 -3 -3 -3 -3 -3 -5 -4 -3 -2 0 0
Costs and Expenses
M 316 336 338 - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
Operating Income
M -345 -361 -362 -372 -367 -351 -346 -334 -340 -330 -318 -305 -270 -221 -169 -119 -85 -66 -67 -76 -87 -96 -104 -104 -99 -96 -96 -104 -115 -121 -174 -185 -235 -204 -127 -85
Interest Expense
M 137 59 126 107 85 64 39 26 20 15 13 12 10 9 6 4 2 0 0 0 0 0 0 1 1 1 1 0 0 0 0 0 0 0 0 0
Non-operating Income/Expense
M -225 -191 -65 -70 -64 -66 -51 -36 -21 -6 3 -1 -1 -8 -9 2 1 1 0 0 0 0 0 -1 -1 -1 -1 0 1 1 4 4 3 2 0 0
EBT
M -601 -584 -459 -474 -431 -417 -401 -378 -372 -350 -327 -307 -269 -226 -173 -121 -85 -66 -68 -76 -87 -97 -104 -104 -100 -97 -97 -105 -115 -121 -174 -185 -235 -204 -127 -85
Income Tax Provision
M 16 51 51 55 34 -1 -1 -1 -1 -1 -1 -2 -2 -2 -2 0 0 0 0 0 0 -1 -1 -1 -1 0 0 0 -1 -1 -1 -1 -1 -1 0 0
Income after Tax
M -618 -635 -510 -530 -465 -417 -400 -377 -371 -349 -326 -305 -267 -224 -171 -121 -85 -66 -67 -76 -87 -96 -103 -104 -99 -96 -96 -104 -115 -121 -173 -184 -234 -204 -127 -84
Non-Controlling Interest
M 0 -1 -1 -1 -1 -1 -1 -2 -2 -3 1 -43 -74 -73 -77 -32 0 - - - - - - - - - - - - - - - - - - -
Net Income
M -138 -254 -362 -473 -430 -417 -400 -376 -370 -347 -291 -225 -157 -115 -101 -79 -59 -22 - - - - - - - - - - - - - - - - - -
Shares (Basic, Weighted)
M - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
Shares (Diluted, Weighted)
R 569,882,643.75 508,770,200.50 441,028,458.00 416,449,555.75 406,583,299.00 398,958,538.00 396,946,850.25 394,895,329.25 391,602,543.25 387,817,299.00 316,915,538.00 314,746,976.25 314,336,698.75 314,446,176.75 312,002,692.25 240,790,772.00 169,644,516.75 94,164,998.25 89,862,163.50 85,080,431.00 80,208,644.25 79,652,472.25 79,096,300.25 79,155,256.75 79,738,658.75 80,514,114.75 81,289,570.75 81,967,977.75 82,097,585.75 81,956,653.50 81,815,721.25 80,736,563.00 79,487,659.00 78,791,975.67 77,400,609.00 76,963,632.00
EBITDA
M -342 -361 -364 -374 -362 -344 -338 -322 -325 -316 -305 -281 -246 -195 -144 -106 -74 -57 -58 -65 -76 -87 -95 -97 -93 -91 -90 -99 -111 -118 -172 -183 -233 -203 -126 -84
Depreciation and Amortization
M 18 16 13 9 5 7 9 12 15 14 13 13 12 13 13 11 9 9 10 10 11 10 8 7 6 6 6 5 4 4 2 1 2 1 1 1
EBIT
M -360 -376 -377 -383 -367 -351 -346 -334 -340 -331 -318 -294 -259 -208 -157 -117 -83 -66 -67 -76 -87 -96 -104 -104 -99 -96 -96 -104 -115 -121 -174 -185 -235 -204 -127 -85
Income from Discontinued Operations
M - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
Tax Rate (Effective)
% -2.57 -9.99 -10.00 -11.15 -7.31 0.15 0.16 0.33 0.27 0.22 0.30 0.70 0.68 0.67 0.69 0.06 0.08 0.14 0.22 0.37 0.48 0.54 0.53 0.50 0.52 0.51 0.49 0.42 0.46 0.48 0.42 0.30 0.28 0.21 0.12 0.59
Earnings Per Share (EPS), Basic
M - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
Earnings Per Share (EPS), Diluted
M 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 - - - - - - - - - - - - - - - - - -
Gross Profit Margin
% -8,818.04 -6,407.14 -7,941.76 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00
Operating Income Margin
% -151,045.27 -99,296.38 -113,173.34 -107,979.77 -112,934.95 -276,564.91 -252,571.23 -263,195.22 -212,657.61 -56,794.15 -40,252.45 -21,297.11 -17,881.36 -7,927.16 -62,978.86 -84,522.07 -106,131.99 -190,161.08 -208,437.27 -195,030.82 -343,932.66 -392,392.66 -381,826.88 -436,767.71 -305,161.46 -222,966.00 -215,146.06 -207,661.69 -237,138.77 -309,588.39 -403,825.89 -443,948.39 -395,882.85 -356,771.58 -259,718.08 -92,946.15
Net Income Margin
% -336,290.24 -184,303.87 -172,282.49 -152,715.68 -136,205.98 -311,744.46 -280,534.46 -290,223.45 -229,171.51 -59,872.72 -47,943.53 -18,356.03 -12,997.18 -4,289.93 -72,246.96 -91,522.21 -134,979.19 -247,511.11 - - - - - - - - - - - - - - - - - -
EBITDA Ratio
% -150,876.92 -101,850.53 -115,873.02 -110,617.37 -111,416.72 -267,785.35 -244,286.82 -253,565.31 -203,363.33 -54,328.21 -38,406.33 -18,465.69 -15,148.71 -5,018.25 -53,494.21 -72,842.81 -92,348.27 -162,016.00 -176,474.73 -165,417.07 -301,839.12 -357,279.12 -353,398.17 -406,012.08 -286,758.51 -210,037.15 -202,202.03 -197,679.11 -228,541.02 -301,610.71 -398,408.93 -440,073.10 -392,804.60 -355,361.68 -259,049.67 -91,859.34
EBIT Ratio
% -158,797.41 -107,048.52 -120,925.48 -114,334.04 -112,934.95 -276,564.91 -252,621.49 -263,234.49 -212,669.89 -56,783.59 -40,252.68 -19,503.86 -16,093.65 -5,953.06 -60,943.70 -84,291.38 -105,922.75 -190,161.08 -208,437.27 -195,030.82 -343,932.66 -392,392.66 -381,826.88 -436,767.71 -305,161.46 -222,966.00 -215,146.06 -207,661.69 -237,138.77 -309,588.39 -403,825.89 -443,948.39 -395,882.85 -356,771.58 -259,718.08 -92,946.15
EBT Ratio
% -239,236.45 -163,501.24 -158,599.42 -153,009.62 -136,472.69 -312,301.65 -281,084.06 -291,028.84 -229,881.22 -60,430.14 -42,863.80 -20,604.72 -16,993.10 -8,187.21 -63,507.05 -84,730.72 -106,280.08 -190,217.05 -208,980.54 -195,683.84 -345,248.17 -393,858.17 -382,845.38 -438,894.17 -306,900.42 -224,624.05 -216,799.35 -208,147.27 -237,349.35 -309,714.88 -403,886.31 -443,948.39 -395,882.85 -356,771.58 -259,718.08 -92,946.15

StockViz Staff

September 20, 2024

Any question? Send us an email